Rchr
J-GLOBAL ID:202301002151154612
Update date: Feb. 02, 2025 Ikenaga Hiroko
イケナガ ヒロコ | Ikenaga Hiroko
Affiliation and department: Research field (3):
Tumor diagnostics and therapeutics
, Internal medicine - General
, Gastroenterology
Research theme for competitive and other funds (2): - 2024 - 2027 エポキシエイコサトリエン酸に着目した肝硬変の病態解明と治療応用
- 2023 - 2025 ミクロゾームエポキシドヒドロラーゼによる肝線維化機序の解明
Papers (6): -
Hideto Yuasa, Tsutomu Matsubara, Hayato Urushima, Atsuko Daikoku, Hiroko Ikenaga, Chiho Kadono, Masahiko Kinoshita, Kenjiro Kimura, Takeaki Ishizawa, Keisuke Ohta, et al. Cdc42 is crucial for the early regulation of hepatic stellate cell activation. American Journal of Physiology-Cell Physiology. 2025
-
Hung Thai Vu, Vien Duc Nguyen, Hiroko Ikenaga, Tsutomu Matsubara. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment. Biomedicines. 2024. 12. 8
-
Hanh Vinh Ngo, Thuy Thi Thanh Le, Hieu Ngoc Vu, Hai Hoang, Hiroko Ikenaga, Misako Sato-Matsubara, Sawako Uchida-Kobayashi, Hayato Urushima, Khanh Van Nguyen, Ha Thi Nguyen, et al. Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40L Linkage. The American journal of pathology. 2024
-
Truong Huu Hoang, Misako Sato-Matsubara, Hideto Yuasa, Tsutomu Matsubara, Le Thi Thanh Thuy, Hiroko Ikenaga, Dong Minh Phuong, Ngo Vinh Hanh, Vu Ngoc Hieu, Dinh Viet Hoang, et al. Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms. Science advances. 2022. 8. 39. eabo5525
-
Hiroko Ikenaga, Sawako Uchida-Kobayashi, Akihiro Tamori, Naoshi Odagiri, Kanako Yoshida, Kohei Kotani, Hiroyuki Motoyama, Ritsuzo Kozuka, Etsushi Kawamura, Atsushi Hagihara, et al. Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment. Journal of viral hepatitis. 2022. 29. 1. 52-59
more... MISC (11): -
池永 寛子, 打田 佐和子, 河田 則文. C型肝炎診療Cutting edge HCV関連初発HCC根治後の腫瘍進行及び予後規定因子の解析. 肝臓. 2024. 65. Suppl.1. A24-A24
-
池永 寛子, 河田 則文. 【膵癌基礎研究の最前線RELOADED】膵癌における膵星細胞の発現とその役割. 胆と膵. 2024. 45. 2. 145-149
-
池永 寛子, 打田 佐和子, 田守 昭博, 小田桐 直志, 吉田 香奈子, 小谷 晃平, 元山 宏行, 小塚 立蔵, 川村 悦史, 萩原 淳司, et al. 直接作用型抗ウイルス薬は肝細胞癌根治後の癌の進行リスクを低減する. 大阪市医学会雑誌. 2023. 72. 25-25
-
池永 寛子, 松原 勤, 河田 則文. 肝疾患の病態に基づいた治療戦略 ミクロソーム型エポキシドヒドロラーゼによる肝線維化機序の解明. 肝臓. 2023. 64. Suppl.2. A542-A542
-
池永 寛子, 松原 勤, 河田 則文. NASH/ASHの病態解明とTransrational Research NAFLD患者サンプル及びNASHモデルマウスを使用した肝線維化に関連する脂肪酸代謝経路の同定 リピドミクス解析によるアプローチ. 肝臓. 2023. 64. Suppl.1. A206-A206
more... Education (2): - 2019 - 2023 Osaka City University (Osaka Metropolitan University) Graduate School of Medicine Department of Hepatology
- 2007 - 2013 大阪市立大学 医学部医学科
Awards (1): - 2024/10 - AASLD NAMED TRAVEL AWARD : the2024 Professor Mindie H. Nguyen Award for Outstanding Research by Early Career Investigators
Return to Previous Page